Literature DB >> 8636037

Characterization of cis-acting mutations in the first attenuator region of the Bacillus subtilis pyr operon that are defective in pyrimidine-mediated regulation of expression.

S Y Ghim1, R L Switzer.   

Abstract

A transcriptional attenuation mechanism for the regulation of pyr operon expression in Bacillus subtilis in which the PyrR regulatory protein binds pyr mRNA at three sites with similar sequences to cause transcription termination in response to elevated pyrimidine nucleotide pools has been proposed (R. J. Turner, Y. Lu, and R. L. Switzer, J. Bacteriol. 176:3708-3722, 1994). Twenty-seven mutants with cis-acting defects in the repression by pyrimidines of beta-galactosidase expression of a pyr-lacZ fusion-integrant were isolated as blue colonies on X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) agar plates containing uracil and uridine after UV irradiation or treatment with mutagens or following mutD mutagenesis. These mutants showed normal repression of the chromosomal pyr operon by exogenous pyrimidines. Sequence analysis revealed 12 unique sites of mutation, which occurred in the conserved putative PyrR binding sequence (10 of the 12) or in the stem of the transcriptional terminator structure. These mutants strongly support the proposed model for regulation of the pyr operon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636037      PMCID: PMC177944          DOI: 10.1128/jb.178.8.2351-2355.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  19 in total

Review 1.  tRNA-directed transcription antitermination.

Authors:  T M Henkin
Journal:  Mol Microbiol       Date:  1994-08       Impact factor: 3.501

2.  Catabolite repression of aconitate hydratase in Bacillus subtilis.

Authors:  D P Cox; R S Hanson
Journal:  Biochim Biophys Acta       Date:  1968-04-16

3.  Modified methods for the determination of carbamyl aspartate.

Authors:  L M Prescott; M E Jones
Journal:  Anal Biochem       Date:  1969-12       Impact factor: 3.365

4.  The structure of trp RNA-binding attenuation protein.

Authors:  A A Antson; J Otridge; A M Brzozowski; E J Dodson; G G Dodson; K S Wilson; T M Smith; M Yang; T Kurecki; P Gollnick
Journal:  Nature       Date:  1995-04-20       Impact factor: 49.962

5.  Regulation of the Bacillus subtilis pyrimidine biosynthetic (pyr) gene cluster by an autogenous transcriptional attenuation mechanism.

Authors:  R J Turner; Y Lu; R L Switzer
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

6.  Regions of the Bacillus subtilis ilv-leu operon involved in regulation by leucine.

Authors:  J A Grandoni; S B Fulmer; V Brizzio; S A Zahler; J M Calvo
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

7.  Construction of a Bacillus subtilis double mutant deficient in extracellular alkaline and neutral proteases.

Authors:  F Kawamura; R H Doi
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

8.  Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA.

Authors:  S N Cohen; A C Chang; L Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

Review 9.  Regulation of the Bacillus subtilis trp operon by an RNA-binding protein.

Authors:  P Gollnick
Journal:  Mol Microbiol       Date:  1994-03       Impact factor: 3.501

10.  Nutritional regulation of degradation of aspartate transcarbamylase and of bulk protein in exponentially growing Bacillus subtilis cells.

Authors:  R W Bond; A S Field; R L Switzer
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

View more
  11 in total

1.  The pyrimidine operon pyrRPB-carA from Lactococcus lactis.

Authors:  J Martinussen; J Schallert; B Andersen; K Hammer
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

2.  Molecular recognition of pyr mRNA by the Bacillus subtilis attenuation regulatory protein PyrR.

Authors:  E R Bonner; J N D'Elia; B K Billips; R L Switzer
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

3.  Characterization of the interaction of Bacillus subtilis PyrR with pyr mRNA by site-directed mutagenesis of the protein.

Authors:  Heather K Savacool; Robert L Switzer
Journal:  J Bacteriol       Date:  2002-05       Impact factor: 3.490

4.  Definition of a second Bacillus subtilis pur regulon comprising the pur and xpt-pbuX operons plus pbuG, nupG (yxjA), and pbuE (ydhL).

Authors:  Lars Engholm Johansen; Per Nygaard; Catharina Lassen; Yvonne Agersø; Hans H Saxild
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

5.  Structure and expression of a pyrimidine gene cluster from the extreme thermophile Thermus strain ZO5.

Authors:  M Van de Casteele; P Chen; M Roovers; C Legrain; N Glansdorff
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

6.  Function of RNA secondary structures in transcriptional attenuation of the Bacillus subtilis pyr operon.

Authors:  Y Lu; R J Turner; R L Switzer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  The Enterococcus faecalis pyr operon is regulated by autogenous transcriptional attenuation at a single site in the 5' leader.

Authors:  S Y Ghim; C C Kim; E R Bonner; J N D'Elia; G K Grabner; R L Switzer
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

8.  Transcriptional pausing in the Bacillus subtilis pyr operon in vitro: a role in transcriptional attenuation?

Authors:  Hesheng Zhang; Robert L Switzer
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

Review 9.  Regulation of pyrimidine biosynthetic gene expression in bacteria: repression without repressors.

Authors:  Charles L Turnbough; Robert L Switzer
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

10.  pyr RNA binding to the Bacillus caldolyticus PyrR attenuation protein - characterization and regulation by uridine and guanosine nucleotides.

Authors:  Casper M Jørgensen; Christopher J Fields; Preethi Chander; Desmond Watt; John W Burgner; Janet L Smith; Robert L Switzer
Journal:  FEBS J       Date:  2008-01-08       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.